What does the evidence say about Iodine Cognition Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Iodine Cognition Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - More and more studies have shown that thyroid disease is associated with cognitive dysfunction. [Shi H (2026); evidence level 3] - While standardized diagnosis and treatment generally yield excellent prognoses, the association between thyroid disorders and cognitive function remains a topic of significant interest. [Shi H (2026); evidence level 3] - Cognitive function includes memory, language, visuospatial ability and executive function. [Shi H (2026); evidence level 3] - Dietary factors may influence cognitive aging and Alzheimer's disease (AD), but observational associations, mechanistic findings, and intervention effects should not be considered equivalent evidence. [Sierralta I (2026); evidence level 4] - Mediterranean, Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND), and healthful plant-based dietary patterns have been associated with better cognitive outcomes and lower dementia risk. [Sierralta I (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.